Setting

North America Nutrigenomics Market 2021-2031 by Offering (Products, Testing Services), Test Technology, Test Sample (Buccal Swab, Saliva, Blood, Others), Application (Women’s Health, Metabolic Disorders, Immune Health, Cancer, Cardiovascular, Diabetes), End User, and Country: Trend Forecast and Growth Opportunity

Published: 30 Jun 2022 | Report Code: 10248543 | Pages: 115

North America nutrigenomics market is projected to grow by 14.8% annually in the forecast period and reach $986.4 million by 2031, driven by the advancements in nutritional & medical technology, the increasing rate of obesity and lifestyle-related diseases, increasing awareness about the relationship between nutrition/gene/health, personalized diet and genetic nutrition profile, and the increasing family disposable incomes. Highlighted with 25 tables and 55 figures, this 115-page report “North America Nutrigenomics Market 2021-2031 by Offering (Products, Testing Services), Test Technology, Test Sample (Buccal Swab, Saliva, Blood, Others), Application (Women’s Health, Metabolic Disorders, Immune Health, Cancer, Cardiovascular, Diabetes), End User, and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire North America nutrigenomics market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.) In-depth qualitative analyses include identification and investigation of the following aspects: • Market Structure • Growth Drivers • Restraints and Challenges • Emerging Product Trends & Market Opportunities • Porter’s Fiver Forces The trend and outlook of North America market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify North America nutrigenomics market in every aspect of the classification from perspectives of Offering, Test Technology, Test Sample, Application, End User, and Country. Based on Offering, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Products o Probiotics o Prebiotics o Vitamins & Supplements • Testing Services o Nutrigenomics Clinical Testing o Nutrigenomics Research Testing Based on Test Technology, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Next-generation Sequencing • Real-time PCR • DNA Microarray • Sanger Sequencing By Test Sample, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Buccal Swab Sample • Saliva Sample • Blood Sample • Other Samples By Application, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Women’s Health • Metabolic Disorders • Immune Health • Cancer Research • Cardiovascular Diseases • Diabetes • Other Applications By End User, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Hospitals • Nutrition Clinics • Diagnostics Laboratories • Other End Users Geographically, the following national/local markets are fully investigated: • U.S. • Canada • Mexico For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of national markets by Offering?Application and End User over the forecast years are also included. The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players. Selected Key Players: BASF SE BioGaia Cell Logic Cura Integrative Medicine DNAfit DuPont de Nemours, Inc. Garden of Life, LLC GeneOmbio Genova Diagnostics, Inc. GX Sciences, Inc. Ingredion Incorporated Jarrow Formulas Inc. Koninklijke DSM N.V. MedGenome Metagenics, Inc. Nutrigenomix Inc. Unilever Group XCODE Life Yakult Honsha Co., Ltd. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

Table of Contents:
1 Introduction 7 1.1 Industry Definition and Research Scope 7 1.1.1 Industry Definition 7 1.1.2 Research Scope 8 1.2 Research Methodology 11 1.2.1 Overview of Market Research Methodology 11 1.2.2 Market Assumption 12 1.2.3 Secondary Data 12 1.2.4 Primary Data 12 1.2.5 Data Filtration and Model Design 13 1.2.6 Market Size/Share Estimation 14 1.2.7 Research Limitations 15 1.3 Executive Summary 16 2 Market Overview and Dynamics 19 2.1 Market Size and Forecast 19 2.1.1 Impact of COVID-19 on World Economy 20 2.1.2 Impact of COVID-19 on the Market 24 2.2 Major Growth Drivers 26 2.3 Market Restraints and Challenges 34 2.4 Emerging Opportunities and Market Trends 37 2.5 Porter’s Fiver Forces Analysis 41 3 Segmentation of North America Market by Offering 45 3.1 Market Overview by Offering 45 3.2 Products 47 3.3.1 Probiotics 48 3.3.2 Prebiotics 49 3.3.3 Vitamins & Supplements 50 3.3 Testing Services 51 3.3.1 Nutrigenomics Clinical Testing 52 3.3.2 Nutrigenomics Research Testing 53 4 Segmentation of North America Market by Test Technology 54 4.1 Market Overview by Test Technology 54 4.2 Next-generation Sequencing 56 4.3 Real-time PCR 57 4.4 DNA Microarray 58 4.5 Sanger Sequencing 59 5 Segmentation of North America Market by Test Sample 60 5.1 Market Overview by Test Sample 60 5.2 Buccal Swab Sample 62 5.3 Saliva Sample 63 5.4 Blood Sample 64 5.5 Other Samples 65 6 Segmentation of North America Market by Application 66 6.1 Market Overview by Application 66 6.2 Women’s Health 68 6.3 Metabolic Disorders 69 6.4 Immune Health 70 6.5 Cancer Research 71 6.6 Cardiovascular Diseases 72 6.7 Diabetes 73 6.8 Other Applications 74 7 Segmentation of North America Market by End User 75 7.1 Market Overview by End User 75 7.2 Hospitals 77 7.3 Nutrition Clinics 78 7.4 Diagnostics Laboratories 79 7.5 Other End Users 80 8 North America Market 2021-2031 by Country 81 8.1 Overview of North America Market 81 8.2 U.S. 84 8.3 Canada 87 8.4 Mexico 89 9 Competitive Landscape 91 9.1 Overview of Key Vendors 91 9.2 New Product Launch, Partnership, Investment, and M&A 94 9.3 Company Profiles 95 BASF SE 95 BioGaia 97 Cell Logic 98 Cura Integrative Medicine 99 DNAfit 100 DuPont de Nemours, Inc. 101 Garden of Life, LLC 102 GeneOmbio 103 Genova Diagnostics, Inc. 104 GX Sciences, Inc. 105 Ingredion Incorporated 106 Jarrow Formulas Inc. 107 Koninklijke DSM N.V. 108 MedGenome 109 Metagenics, Inc. 110 Nutrigenomix Inc. 111 Unilever Group 112 XCODE Life 113 Yakult Honsha Co., Ltd. 114 RELATED REPORTS 115 ?
List of Tables:

Table 1.  Snapshot of North America Nutrigenomics Market in Balanced Perspective, 2021-2031	17
Table 2. World Economic Outlook, 2021-2031	21
Table 3. World Economic Outlook, 2021-2023	22
Table 4. World Health Spending by Region, $ bn, 2013-2020	33
Table 5.  Main Product Trends and Market Opportunities in North America Nutrigenomics Market	37
Table 6. North America Nutrigenomics Market by Offering, 2021-2031, $ mn	45
Table 7. North America Nutrigenomics Market: Products by Type, 2021-2031, $ mn	47
Table 8. North America Nutrigenomics Market: Testing Services by Type, 2021-2031, $ mn	51
Table 9. North America Nutrigenomics Market by Test Technology, 2021-2031, $ mn	54
Table 10. North America Nutrigenomics Market by Test Sample, 2021-2031, $ mn	60
Table 11. North America Nutrigenomics Market by Application, 2021-2031, $ mn	66
Table 12. North America Nutrigenomics Market by End User, 2021-2031, $ mn	75
Table 13. North America Nutrigenomics Market by Country, 2021-2031, $ mn	82
Table 14. U.S. Nutrigenomics Market by Offering, 2021-2031, $ mn	86
Table 15. U.S. Nutrigenomics Market by Application, 2021-2031, $ mn	86
Table 16. U.S. Nutrigenomics Market by End User, 2021-2031, $ mn	86
Table 17. Canada Nutrigenomics Market by Offering, 2021-2031, $ mn	88
Table 18. Canada Nutrigenomics Market by Application, 2021-2031, $ mn	88
Table 19. Canada Nutrigenomics Market by End User, 2021-2031, $ mn	88
Table 20. Mexico Nutrigenomics Market by Offering, 2021-2031, $ mn	90
Table 21. Mexico Nutrigenomics Market by Application, 2021-2031, $ mn	90
Table 22. Mexico Nutrigenomics Market by End User, 2021-2031, $ mn	90
Table 23. BASF SE: Company Snapshot	95
Table 24. BASF SE: Business Segmentation	96
Table 25. BASF SE: Product Portfolio	96
List of Figures:

Figure 1. Research Method Flow Chart	11
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation	14
Figure 3. North America Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2021-2031	16
Figure 4. North America Nutrigenomics Market, 2021-2031, $ mn	19
Figure 5. Impact of COVID-19 on Business	24
Figure 6. Primary Drivers and Impact Factors of North America Nutrigenomics Market	26
Figure 7. Number of Overweight/Obese People and Diabetic Population in the World, 1980, 2020, and 2045F, in million	29
Figure 8.  Leading Causes of Death in the World, 2019-2020, million	31
Figure 9.  Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million	32
Figure 10. World Population 65 and Over, % of Total Population, 1950-2060	32
Figure 11. Primary Restraints and Impact Factors of North America Nutrigenomics Market	34
Figure 12. Investment Opportunity Analysis	38
Figure 13. Porter’s Fiver Forces Analysis of North America Nutrigenomics Market	41
Figure 14. Breakdown of North America Nutrigenomics Market by Offering, 2021-2031, % of Revenue	46
Figure 15. North America Addressable Market Cap in 2022-2031 by Offering, Value ($ mn) and Share (%)	46
Figure 16. North America Nutrigenomics Market by Offering: Products, 2021-2031, $ mn	47
Figure 17. North America Nutrigenomics Market by Products: Probiotics, 2021-2031, $ mn	48
Figure 18. North America Nutrigenomics Market by Products: Prebiotics, 2021-2031, $ mn	49
Figure 19. North America Nutrigenomics Market by Products: Vitamins & Supplements, 2021-2031, $ mn	50
Figure 20. North America Nutrigenomics Market by Offering: Testing Services, 2021-2031, $ mn	51
Figure 21. North America Nutrigenomics Market by Testing Services: Nutrigenomics Clinical Testing, 2021-2031, $ mn	52
Figure 22. North America Nutrigenomics Market by Testing Services: Nutrigenomics Research Testing, 2021-2031, $ mn	53
Figure 23. Breakdown of North America Nutrigenomics Market by Test Technology, 2021-2031, % of Sales Revenue	55
Figure 24. North America Addressable Market Cap in 2022-2031 by Test Technology, Value ($ mn) and Share (%)	55
Figure 25. North America Nutrigenomics Market by Test Technology: Next-generation Sequencing, 2021-2031, $ mn	56
Figure 26. North America Nutrigenomics Market by Test Technology: Real-time PCR, 2021-2031, $ mn	57
Figure 27. North America Nutrigenomics Market by Test Technology: DNA Microarray, 2021-2031, $ mn	58
Figure 28. North America Nutrigenomics Market by Test Technology: Sanger Sequencing, 2021-2031, $ mn	59
Figure 29. Breakdown of North America Nutrigenomics Market by Test Sample, 2021-2031, % of Sales Revenue	61
Figure 30. North America Addressable Market Cap in 2022-2031 by Test Sample, Value ($ mn) and Share (%)	61
Figure 31. North America Nutrigenomics Market by Test Sample: Buccal Swab Sample, 2021-2031, $ mn	62
Figure 32. North America Nutrigenomics Market by Test Sample: Saliva Sample, 2021-2031, $ mn	63
Figure 33. North America Nutrigenomics Market by Test Sample: Blood Sample, 2021-2031, $ mn	64
Figure 34. North America Nutrigenomics Market by Test Sample: Other Samples, 2021-2031, $ mn	65
Figure 35. Breakdown of North America Nutrigenomics Market by Application, 2021-2031, % of Revenue	67
Figure 36. North America Addressable Market Cap in 2022-2031 by Application, Value ($ mn) and Share (%)	67
Figure 37. North America Nutrigenomics Market by Application: Women’s Health, 2021-2031, $ mn	68
Figure 38. North America Nutrigenomics Market by Application: Metabolic Disorders, 2021-2031, $ mn	69
Figure 39. North America Nutrigenomics Market by Application: Immune Health, 2021-2031, $ mn	70
Figure 40. North America Nutrigenomics Market by Application: Cancer Research, 2021-2031, $ mn	71
Figure 41. North America Nutrigenomics Market by Application: Cardiovascular Diseases, 2021-2031, $ mn	72
Figure 42. North America Nutrigenomics Market by Application: Diabetes, 2021-2031, $ mn	73
Figure 43. North America Nutrigenomics Market by Application: Other Applications, 2021-2031, $ mn	74
Figure 44. Breakdown of North America Nutrigenomics Market by End User, 2021-2031, % of Revenue	76
Figure 45. North America Addressable Market Cap in 2022-2031 by End User, Value ($ mn) and Share (%)	76
Figure 46. North America Nutrigenomics Market by End User: Hospitals, 2021-2031, $ mn	77
Figure 47. North America Nutrigenomics Market by End User: Nutrition Clinics, 2021-2031, $ mn	78
Figure 48. North America Nutrigenomics Market by End User: Diagnostics Laboratories, 2021-2031, $ mn	79
Figure 49. North America Nutrigenomics Market by End User: Other End Users, 2021-2031, $ mn	80
Figure 50. Breakdown of North America Nutrigenomics Market by Country, 2021 and 2031, % of Revenue	82
Figure 51. Contribution to North America 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%)	83
Figure 52. U.S. Nutrigenomics Market, 2021-2031, $ mn	85
Figure 53. Canada Nutrigenomics Market, 2021-2031, $ mn	87
Figure 54.  Nutrigenomics Market in Mexico, 2021-2031, $ mn	89
Figure 55. Growth Stage of North America Nutrigenomics Industry over the Forecast Period	91
Selected Key Players: 
BASF SE
BioGaia
Cell Logic
Cura Integrative Medicine
DNAfit
DuPont de Nemours, Inc.
Garden of Life, LLC
GeneOmbio
Genova Diagnostics, Inc.
GX Sciences, Inc.
Ingredion Incorporated
Jarrow Formulas Inc.
Koninklijke DSM N.V.
MedGenome
Metagenics, Inc.
Nutrigenomix Inc.
Unilever Group
XCODE Life
Yakult Honsha Co., Ltd.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)